Expression of oncogenic HMGN5 increases the sensitivity of prostate cancer cells to gemcitabine

Publisher： Spandidos Publications

E-ISSN： 1791-2431|33|3|1519-1525

ISSN： 1021-335X

Source： Oncology Reports, Vol.33, Iss.3, 2015-01, pp. : 1519-1525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine increases systemic 5-fluorouracil exposure in advanced cancer patients

By Correale P.   Cerretani D.   Marsili S.   Pozzessere D.   Petrioli R.   Messinese S.   Sabatino M.   Roviello F.   Pinto E.   Francini G.   Giorgi G.  

European Journal of Cancer, Vol. 39, Iss. 11, 2003-07 ,pp. : 1547-1551

Elsevier

Access to resources Recommend Favorite

Cisplatin in combination with programmed cell death protein 5 increases antitumor activity in prostate cancer cells by promoting apoptosis

By      

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4561-4566

Spandidos Publications

Access to resources Recommend Favorite

PDCD5 transfection increases cisplatin sensitivity and decreases invasion in hepatic cancer cells

By  

Oncology Letters, Vol. 9, Iss. 1, 2015-01 ,pp. : 411-417

Spandidos Publications

Access to resources Recommend Favorite

Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells

By            

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1581-1589

Spandidos Publications

Access to resources Recommend Favorite

Hypoxia increases CX3CR1 expression via HIF-1 and NFκB in androgen-independent prostate cancer cells

By                      

International Journal of Oncology, Vol. 41, Iss. 5, 2012-01 ,pp. : 1827-1836

Spandidos Publications

Access to resources Recommend Favorite